Table E3.

Indications for TAVR explant

Study	SVD, n	PVL/aortic insufficiency, n	Aortic stenosis, n	Endocarditis, n	Failed implantation, n
Mangner et al, 20188	N/A	N/A	N/A	20	N/A
Jawitz et al, 20209∗	N/A	N/A	N/A	N/A	N/A
Nakazato et al, 202010	N/A	N/A	N/A	N/A	N/A
Hirji et al, 202011	180	0	N/A	47	0
Tang et al, 202012	55	46	N/A	115	10
Fukuhara et al, 202113†	N/A	N/A	N/A	N/A	N/A
Brescia et al, 202114‡	4	8	1	4	3
Fukuhara et al, 202115	51	168	158	138	211
Malvindi et al, 202116	4	0	0	6	0
Fukuhara et al, 202117§	19	25	11	38	52

TAVR, Transcatheter aortic valve replacement; SVD, structural valve degeneration; PVL, paravalvular leak; N/A, not applicable.

^∗All data were excluded owing to potential duplication with reference 15.

^†All data were excluded owing to potential duplication with reference 15.

^‡Data between 2012 and 2018 were excluded owing to potential duplication with references 13 and 15.

^§Data between 2016 and 2018 were excluded owing to duplication with reference 15.